Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
6.84
+0.05 (0.74%)
At close: Apr 28, 2026, 4:00 PM EDT
6.89
+0.05 (0.73%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Vanda Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Vanda Pharmaceuticals stock have an average target of 14.9, with a low estimate of 7.50 and a high estimate of 24. The average target predicts an increase of 117.84% from the current stock price of 6.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 5, 2026.
Analyst Ratings
The average analyst rating for Vanda Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +163.16% | Mar 5, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +250.88% | Feb 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +221.64% | Jan 5, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $14 | Strong Buy | Maintains | $11 → $14 | +104.68% | Dec 31, 2025 |
| Jefferies | Jefferies | Hold Maintains $5 → $7.5 | Hold | Maintains | $5 → $7.5 | +9.65% | Dec 31, 2025 |
Financial Forecast
Revenue This Year
262.25M
from 216.11M
Increased by 21.35%
Revenue Next Year
360.34M
from 262.25M
Increased by 37.40%
EPS This Year
-2.43
from -3.74
EPS Next Year
-0.87
from -2.43
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 281.2M | 422.7M | |
| Avg | 262.3M | 360.3M | |
| Low | 245.0M | 319.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.1% | 61.2% | |
| Avg | 21.4% | 37.4% | |
| Low | 13.4% | 21.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.25 | -0.45 | |
| Avg | -2.43 | -0.87 | |
| Low | -2.73 | -1.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.